Bird & Bird LLP's Equity Capital Markets team successfully close 17 deals in Q1 2020

Despite the turbulent marketplace across the globe due to the COVID-19 pandemic, our Equity Capital Markets Team has completed 17 deals this Quarter, across a wide variety of sectors. 

"It's really encouraging so see the team successfully close such an impressive range of ECM transactions in such challenging circumstances. There is a healthy spread of deals across the international Markets we are active in and we pay particular tribute to the team in Hong Kong, who have had to live with turbulent markets for more than a year; they closed the first IPO of 2020 on the HK Exchange, in January. We thank all of our clients and relationship banks and brokers for all their support in these extraordinary times" says Clive Hopewell, Head of International Equity Capital Markets at Bird & Bird.

In the next few weeks the Equity Capital Markets Team will be publishing a webinar discussing the differing circumstances across our key jurisdictions, as well as predictions for stock exchanges when lockdown eases.

View our Q1 2020 Deal Highlights here >

News & Deals

More News & Deals

News

Bird & Bird ATMD advised lead investor Hatch Blue in agritech startup Peptobiotics' US$6.2 million Series A funding

Apr 15 2024

Read More

Deal

Bird & Bird advises P2X Solutions on financing arrangement

Apr 15 2024

Read More

News

Bird & Bird advises EFESO on the acquisition of Aioneers GmbH

Apr 12 2024

Read More

News

Bird & Bird Dominates European Managing IP Awards with Nine Victories

Apr 11 2024

Read More

Deal

Bird & Bird advises on AIM IPO of European Green Transition plc.

Apr 10 2024

Read More

Deal

Bird & Bird assist Novo Nordisk Foundation and Danish Centre for AI in AI supercomputer initiative

Apr 10 2024

Read More

Related capabilities